Clinical Trial of YH32364 in Patients With Locally Advanced or Metastatic EGFR Overexpressing Solid Tumors | MicrobiomeTrials← Back to trialsNCT06975410
Clinical Trial of YH32364 in Patients With Locally Advanced or Metastatic EGFR Overexpressing Solid Tumors
RecruitingPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2025-06-12Est. Completion: 2027-06
Enrollment target: 80 participants Locations- Korea University Anam Hospital, Seoul, South Korea
- Seoul National University Hospital, Seoul, South Korea
- Severance Hospital, Seoul, South Korea
- Samsung Medical Center, Seoul, South Korea
Other microbiome trials you might be interested in
Breast CancerGastric CancerEsophageal CancerGastroesophageal CancerColorectal CancerEndometrial CancerNon-small Cell Lung CancerOvarian CancerUrothelial CarcinomaSalivary Gland CancerPancreatic CancerHER-2 Protein Overexpression
The purpose of this study is to evaluate the efficacy and safety of zanidatamab for the treatment of participants with p…
Prescott, United StatesEst. completion Dec 31, 2026
Phase 1
Recruiting
GlioblastomaBrain CancerBrain NeoplasmBrain TumorBrain Neoplasm, MalignantEGFR Gene OverexpressionGBM
Primary brain cancer kills up to 10,000 Americans a year. These brain tumors are typically treated by surgery, radiation…
New York, United StatesEst. completion Dec 2028